Cargando…

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation

Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanzawa, Noriyuki, Nishigaki, Kazuo, Hayashi, Takaya, Ishii, Yuichi, Furukawa, Souichi, Niiro, Ayako, Yasui, Fumihiko, Kohara, Michinori, Morita, Kouichi, Matsushima, Kouji, Le, Mai Quynh, Masuda, Takao, Kannagi, Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094718/
https://www.ncbi.nlm.nih.gov/pubmed/17141229
http://dx.doi.org/10.1016/j.febslet.2006.11.046
_version_ 1783510527872335872
author Kanzawa, Noriyuki
Nishigaki, Kazuo
Hayashi, Takaya
Ishii, Yuichi
Furukawa, Souichi
Niiro, Ayako
Yasui, Fumihiko
Kohara, Michinori
Morita, Kouichi
Matsushima, Kouji
Le, Mai Quynh
Masuda, Takao
Kannagi, Mari
author_facet Kanzawa, Noriyuki
Nishigaki, Kazuo
Hayashi, Takaya
Ishii, Yuichi
Furukawa, Souichi
Niiro, Ayako
Yasui, Fumihiko
Kohara, Michinori
Morita, Kouichi
Matsushima, Kouji
Le, Mai Quynh
Masuda, Takao
Kannagi, Mari
author_sort Kanzawa, Noriyuki
collection PubMed
description Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF‐κB) and c‐Jun N‐terminal kinase (JNK), and significantly enhanced interleukin 8 (IL‐8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up‐regulated in SARS‐CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS.
format Online
Article
Text
id pubmed-7094718
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70947182020-03-25 Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation Kanzawa, Noriyuki Nishigaki, Kazuo Hayashi, Takaya Ishii, Yuichi Furukawa, Souichi Niiro, Ayako Yasui, Fumihiko Kohara, Michinori Morita, Kouichi Matsushima, Kouji Le, Mai Quynh Masuda, Takao Kannagi, Mari FEBS Lett Short Communications Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF‐κB) and c‐Jun N‐terminal kinase (JNK), and significantly enhanced interleukin 8 (IL‐8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up‐regulated in SARS‐CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS. John Wiley and Sons Inc. 2006-12-22 2006-11-27 /pmc/articles/PMC7094718/ /pubmed/17141229 http://dx.doi.org/10.1016/j.febslet.2006.11.046 Text en FEBS Letters 580 (2006) 1873-3468 © 2015 Federation of European Biochemical Societies This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
spellingShingle Short Communications
Kanzawa, Noriyuki
Nishigaki, Kazuo
Hayashi, Takaya
Ishii, Yuichi
Furukawa, Souichi
Niiro, Ayako
Yasui, Fumihiko
Kohara, Michinori
Morita, Kouichi
Matsushima, Kouji
Le, Mai Quynh
Masuda, Takao
Kannagi, Mari
Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title_full Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title_fullStr Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title_full_unstemmed Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title_short Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
title_sort augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/x1 and 7a/x4 proteins through nf‐κb activation
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094718/
https://www.ncbi.nlm.nih.gov/pubmed/17141229
http://dx.doi.org/10.1016/j.febslet.2006.11.046
work_keys_str_mv AT kanzawanoriyuki augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT nishigakikazuo augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT hayashitakaya augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT ishiiyuichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT furukawasouichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT niiroayako augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT yasuifumihiko augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT koharamichinori augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT moritakouichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT matsushimakouji augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT lemaiquynh augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT masudatakao augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation
AT kannagimari augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation